🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of acetaminophen, alleging the companies hid safety concerns that the pain reliever posed to children's brain development.

The lawsuit follows thirty days after Donald Trump advocated an unsubstantiated connection between taking Tylenol - also known as paracetamol - while pregnant and autism in offspring.

The attorney general is suing J&J, which formerly manufactured the medication, the only pain reliever suggested for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he said they "misled consumers by making money from discomfort and promoting medication without regard for the risks."

The manufacturer says there is no credible evidence linking Tylenol to autism.

"These corporations deceived for years, knowingly endangering millions to line their pockets," Paxton, from the Republican party, said.

The manufacturer commented that it was "very worried by the spread of false claims on the reliability of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its official site, Kenvue also said it had "regularly reviewed the applicable studies and there is insufficient valid information that indicates a proven link between taking acetaminophen and autism."

Associations representing doctors and health professionals share this view.

ACOG has said acetaminophen - the key substance in acetaminophen - is a restricted selection for pregnant women to treat pain and fever, which can create major wellness concerns if ignored.

"In more than two decades of investigation on the utilization of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the use of paracetamol in any period of pregnancy results in brain development issues in offspring," the organization stated.

This legal action references current declarations from the former administration in arguing the drug is reportedly hazardous.

Recently, Trump generated worry from public health officials when he instructed women during pregnancy to "struggle intensely" not to consume acetaminophen when unwell.

The US Food and Drug Administration then released a statement that physicians should contemplate reducing the consumption of Tylenol, while also declaring that "a proven link" between the drug and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had pledged in April to undertake "a massive testing and research effort" that would identify the source of autism in a limited time.

But authorities advised that discovering a sole reason of autism spectrum disorder - considered by experts to be the consequence of a intricate combination of genetic and environmental factors - would prove challenging.

Autism is a category of lifelong neurodivergence and condition that affects how individuals perceive and interact with the environment, and is identified using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is seeking the Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the corporations "eliminate any commercial messaging" that states Tylenol is reliable for pregnant women.

This legal action parallels the grievances of a assembly of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in recently.

Judicial authorities dismissed the lawsuit, stating investigations from the family's specialists was lacking definitive proof.